In cell experiments, GLP-1 was found to have more mechanisms that may inhibit liver fat synthesis, such as FAM3A, NRF2, NaB, SHP1/AMPK, NLRP3, FGF21, IRS2, and other signaling pathways, which also provided direct evidence for the role of GLP-1R in the regulation of lipid metabolism in the liver
Type 2 Diabetes A diagnosis with ICD-10-CM codes E11*
Unlike FDA-approved medications that produce substantial, clinically proven weight loss, these dietary supplements lack regulatory approval and rigorous efficacy testing
Other GLP-1s and related agents Dulaglutide, exenatide and other GLP-1 RAs used primarily for diabetes generally produce modest weight loss compared with the agents above
Step 4 - Ongoing care & adjustments
Youre familiar with the benefits, but you could have mild or not-so-mild side effects, too